ISB News

Aitchison Lab Accepts ALS Ice Bucket Challenge

Jennifer Smith, senior research scientist in the John Aitchison Lab, was tagged to do the ALS Ice Bucket Challenge. And because the Aitchison group studies ALS, Jennifer’s lab mates took the challenge, too. Jennifer offered this description of the work they are doing to create a blood test for early detection of ALS:

ISB is developing a multi-component blood-based assay (blood test) for early detection and disease tracking of ALS. We are doing this because there are no good diagnostic tests for ALS and, on average, it takes a year to get a definitive diagnosis, resulting in significant loss of therapeutic opportunity. There is a dire need for a robust and quantitative blood biomarker assay to help confirm initial diagnosis of ALS and to track disease activity not only for clinical use, but to also to develop new therapies for the disease.

The assay we are developing is called the indicator cell assay platform (iCAP) for blood-based diagnostics that can be used for early detection of ALS, and as a diagnostic tool for drug development. The iCAP uses cultured cells as biosensors, capitalizing on the natural ability of cells to detect signals present in serum from patients with ALS with exquisite sensitivity, as opposed to traditional assays that rely on direct detection of molecules in blood.

You can support ALSA.org to raise awareness about ALS. Or you can support ALS research directly with a gift to Institute for Systems Biology. Support ALS research directly.

You Have 24 Hours to Accept the Challenge!

And now, the Aitchison Lab challenges the following groups:

  • Mike Rout Lab, The Rockefeller University
  • Alan Aderem Lab, Seattle BioMed
  • Dave Goodlett Lab, University of Maryland

Learn more about the Aitchison Lab and Jennifer Smith. Jennifer received a “proof of concept” grant from the Life Sciences Discovery Fund to develop a similar early detection test for Alzheimer’s.

Ice Bucket Challenge Photo Gallery

You may also visit the full gallery on Flickr.

ALS5614 ALS5615 ALS5616

Recent Articles

  • View of the responsive recruitment website and electronic consent platform as seen on mobile phone and desktop devices.

    ISB Builds a Digital Platform for COVID-19 Research Study – And Beyond

    In a multi-institutional study of a highly infectious disease like COVID-19, paperless consent for study participants is critical. One component of the COVID-19 Immune Response Study is a recruitment website with an IRB-approved and HIPAA-compliant electronic consent platform for enrolling patients.

  • Reshaping STEM Education Toward a More Equitable Future for Students

    ISB Assistant Professor Dr. Sean Gibbons recently participated in a virtual event titled “Reshaping STEM Education Toward Equitable Futures for Washington Students.” Panelists shared their insights about how to leverage this complex moment to reshape STEM education toward equity, sustainability, and prosperity for Washington state’s students — especially those furthest from opportunity.

  • Shmulevich-Thorsson

    ISB Researchers Among Recipients of AACR Team Science Award

    The American Association for Cancer Research (AACR) has recognized The Cancer Genome Atlas (TCGA) project with the 2020 AACR Team Science Awards. Award recipients include Dr. Ilya Shmulevich, ISB professor and head of the Shmulevich Lab; ISB senior research scientist Dr. Vésteinn Þórsson; and former Shmulevich Lab members Drs. Brady Bernard and Theo Knijnenburg.